New research could pave the way to developing cancer drugs targeting an enzyme that inhibits ferroptosis, a type of cell death. Cancer cells that are resistant to anticancer drugs are known to be vulnerable to ferroptosis. Therefore, agents that effectively induce or enhance the sensitivity of cancer cells to ferroptosis are expected to become novel anticancer agents.
New method can evaluate enzyme involved in process associated with cancer cell death
